Since 2013, RoosterBio has been fueling the rapid commercialization of scalable regenerative cures by providing a solution to the hMSC industry bottleneck, simplifying and standardizing how living cells are purchased, expanded, and used in development.
In this webinar, we explore traditional challenges associated with the incorporation of human mesenchymal stem cells into cell therapies and the advances being made to improve clinical manufacturing readiness.
RoosterGEM is the industry's first genetic engineering medium, and in this webinar, you will learn how it can improve transduction efficiency and reduce MOI, leading to lower vector and media costs.
The goal of this webinar is to discuss the importance of building a strong cost model with a step-by-step MSC-based example and how your model can positively impact your product and process development.
This webinar will cover challenges and options available for cell therapy product developers in scaling production, including industry best practices that will deliver rapid, safe, and cost-effective solutions to meet the crisis demand.
This presentation highlights strategies and systems that radically simplify the production of large quantities of EVs, as well as cGMP raw material requirements for rapid clinical translation.
In this webinar, we discuss the manufacturing of EVs derived from mesenchymal stem cells, including the tissue source, cell state, and process parameters, and the importance of evaluating productivity in manufacturing processes.
The focus of this talk is the scale-up of MSC and EV production in bioreactors, including processes for successful commercialization of cell therapy products and quality EV production with the end goal in mind.
Subscribe to our channel to stay up-to-date on our complete library of FAQs, interviews, presentations, and more. Improve your knowledge of hMSCs and other Regenerative Medicine topics, as we strive to bring our expertise to the forefront of industry discourse, education, and pioneering.
RoosterBio is proud to announce our next live webinar: Strategic Considerations for Scalable Product and Process Development to Industrialize Your Cell-Manufacturing Supply Chain. In this session we will discuss:
Stay tuned for future updates, as well as other new and improved content.
